{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T13:25:00Z","timestamp":1786886700212,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012964","name":"Enseignement Sup\u00e9rieur et de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cyto.2026.157139","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:04:40Z","timestamp":1774652680000},"page":"157139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comprehensive analysis of immune mediators in triple-negative breast cancer: Disclosing potential diagnostic and prognostic biomarkers"],"prefix":"10.1016","volume":"202","author":[{"given":"Azza","family":"Habel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryem","family":"Bessaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"stayoussef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanen","family":"Bouaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Ayadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Larbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma","family":"Yaacoubi-Loueslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cyto.2026.157139_bb0005","first-page":"565","article-title":"Breast cancer: epidemiology, risk factors and screening","volume":"35","author":"Xu","year":"2023","journal-title":"Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu"},{"key":"10.1016\/j.cyto.2026.157139_bb0010","series-title":"Breast Cancer [Internet]","article-title":"Subtypes of breast Cancer","author":"Orrantia-Borunda","year":"2022"},{"key":"10.1016\/j.cyto.2026.157139_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.836417","article-title":"Triple-negative breast Cancer: a brief review about epidemiology, risk factors, Signaling pathways, treatment and role of artificial intelligence","volume":"9","author":"Almansour","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cyto.2026.157139_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CMAR.S316700","article-title":"The characteristics of tumor microenvironment in triple negative breast Cancer","volume":"14","author":"Fan","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.cyto.2026.157139_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/mi\/8441796","article-title":"Identification and characterization of cytokine genes in breast Cancer for predicting clinical outcomes","volume":"2025","author":"Han","year":"2025","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2026.157139_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217865","article-title":"The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): emerging therapeutic opportunities","volume":"628","author":"Sabit","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cyto.2026.157139_bb0035","first-page":"725","article-title":"Prognostic and predictive biomarkers in triple negative breast Cancer (TNBC): a comparative study of glycolysis, inflammatory markers, melatonin, neurotransmitters and metalloproteinases","volume":"15","author":"Tavartkiladze","year":"2024","journal-title":"Journal of Clinical & Cellular Immunology"},{"issue":"15","key":"10.1016\/j.cyto.2026.157139_bb0040","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.3390\/ijms26157430","article-title":"Multiplex immunofluorescence reveals therapeutic targets EGFR, EpCAM, tissue factor, and TROP2 in triple-negative breast cancer","volume":"26","author":"Mohiuddin TM","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cyto.2026.157139_bb0080","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast Cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cyto.2026.157139_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.598532","article-title":"The roles of stroma-derived chemokine in different stages of Cancer metastases","volume":"11","author":"Hussain","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2026.157139_bb0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/imm.13627","article-title":"Systemic immune mediators reflect tumour-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast cancer","volume":"169","author":"Lopes","year":"2023","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.cyto.2026.157139_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13081945","article-title":"Cytokine networks in triple-negative breast cancer: mechanisms, therapeutic targets, and emerging strategies","volume":"13","author":"Rosado-Sanz","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.cyto.2026.157139_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156051","article-title":"Identification of two theranostic biomarker panels for epithelial ovarian cancer","volume":"161","author":"Habel","year":"2023","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.cyto.2026.157139_bb0065","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/cancers12061383","article-title":"Eotaxins and their receptor in colorectal Cancer\u2014a literature review","volume":"12","author":"Zajkowska","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.cyto.2026.157139_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156409","article-title":"Assessing serum cytokine profiles in inflammatory breast cancer patients using Luminex\u00ae technology","volume":"172","author":"Bessaad","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2026.157139_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1254694","article-title":"The role of angiogenic growth factors in the immune microenvironment of glioma","volume":"13","author":"Ge","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2026.157139_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/vaccines13010069","article-title":"Efficacy of anti-Cancer immune responses elicited using tumor-targeted IL-2 cytokine and its derivatives in combined preclinical therapies","volume":"13","author":"Balkhi","year":"2025","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.cyto.2026.157139_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-065X.2011.01004.x","article-title":"T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells","volume":"241","author":"Cheng","year":"2011","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.cyto.2026.157139_bb0100","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.4049\/jimmunol.1200385","article-title":"IL-17 and TNF-\u03b1 sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation","volume":"188","author":"Griffin","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2026.157139_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2026.157139_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1189\/jlb.0204065","article-title":"Interleukin-17 regulates expression of the CXC chemokine LIX\/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment","volume":"76","author":"Ruddy","year":"2004","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.cyto.2026.157139_bb0115","first-page":"2729","article-title":"Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection","volume":"186","author":"Novy","year":"2011","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"key":"10.1016\/j.cyto.2026.157139_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1411047","article-title":"IL-3: key orchestrator of inflammation","volume":"15","author":"Podolska","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2026.157139_bb0125","doi-asserted-by":"crossref","first-page":"9908","DOI":"10.18632\/oncotarget.3532","article-title":"Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis","volume":"6","author":"De Simone","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2026.157139_bb0130","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/849720","article-title":"The role of chemokines in breast cancer pathology and its possible use as therapeutic targets","volume":"2014","author":"Palacios-Arreola","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cyto.2026.157139_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155909","article-title":"Role of chemokines in breast cancer","volume":"155","author":"Masih","year":"2022","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.cyto.2026.157139_bb0145","doi-asserted-by":"crossref","first-page":"358","DOI":"10.31083\/j.fbl2910358","article-title":"Roles of chemokine axes in breast Cancer","volume":"29","author":"Son","year":"2024","journal-title":"Frontiers in Bioscience (Landmark edition)"},{"key":"10.1016\/j.cyto.2026.157139_bb0150","first-page":"1563","article-title":"Immunology of IL-12: an update on functional activities and implications for disease","volume":"19","author":"Ullrich","year":"2020","journal-title":"EXCLI J."},{"issue":"3","key":"10.1016\/j.cyto.2026.157139_bb0165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","article-title":"Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer","volume":"57","author":"Shouse","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2026.157139_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1479505","article-title":"The role of interleukin-17 in inflammation-related cancers","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2026.157139_bb0175","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317714624","article-title":"TWEAK\/Fn14 signaling in tumors","volume":"39","author":"Hu","year":"2017","journal-title":"Tumour Biol.: J. Int. Soc. Oncodevelop. Biol. Med."},{"key":"10.1016\/j.cyto.2026.157139_b9000","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/bjc.2015.193","article-title":"Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome","volume":"113","author":"Cambien","year":"2015","journal-title":"British J. Cancer"},{"issue":"10","key":"10.1016\/j.cyto.2026.157139_bib206","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-10-4316","article-title":"Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells","volume":"71","author":"Olkhanud","year":"2011","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.cyto.2026.157139_bb0180","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.7150\/jca.46301","article-title":"Identification of CTLA-4 associated with tumor microenvironment and competing interactions in triple negative breast cancer by co-expression network analysis","volume":"11","author":"Peng","year":"2020","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.cyto.2026.157139_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13081945","article-title":"Cytokine networks in triple-negative breast cancer: mechanisms, therapeutic targets, and emerging strategies","volume":"13","author":"Rosado-Sanz M","year":"2025","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cyto.2026.157139_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/00368504211039590","article-title":"Soluble interleukin-2 receptor as a predictive and prognostic marker for patients with familial breast cancer","volume":"104","author":"Gonda","year":"2021","journal-title":"Sci. Prog."},{"key":"10.1016\/j.cyto.2026.157139_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115267","article-title":"The role of IL-8 in cancer development and its impact on immunotherapy resistance","volume":"218","author":"Meier","year":"2025","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"key":"10.1016\/j.cyto.2026.157139_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1627235","article-title":"TSLP: contrasting roles in cancer","volume":"16","author":"Poto","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2026.157139_bb0205","series-title":"General Methods in Biomarker Research and their Applications","first-page":"223","article-title":"Macrophage inflammatory Protein-1 alpha (MIP-1 alpha)\/CCL3: as a biomarker","author":"Bhavsar","year":"2015"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:38:49Z","timestamp":1786883929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S1043466626000347"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157139","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of immune mediators in triple-negative breast cancer: Disclosing potential diagnostic and prognostic biomarkers","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"157139"}}